These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24117126)

  • 1. Management of Hypertension-Journey from Single Drug Therapy to Multitargeted Ligand Therapy: A Clinical Overview.
    Naik P; Gandhi H; Pawar V; Giridhar R; Yadav MR
    Curr Clin Pharmacol; 2015; 10(4):321-46. PubMed ID: 24117126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform.
    Volpe M; Tocci G; de la Sierra A; Kreutz R; Laurent S; Manolis AJ; Tsioufis K
    High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):463-472. PubMed ID: 29086364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhering to the principles of clinical pharmacology - the correct fixed combinations of antihypertensive drugs.
    Lopatowska P; Mlodawska E; Tomaszuk-Kazberuk A; Banach M; Malyszko J
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):165-170. PubMed ID: 29192802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapy.
    Tocci G; Volpe M
    Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):829-40. PubMed ID: 21809963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add?
    Thomopoulos C; Katsimagklis G; Archontakis S; Skalis G; Makris T
    Curr Vasc Pharmacol; 2017; 16(1):61-65. PubMed ID: 28413969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.
    Chrysant SG; Germino FW; Neutel JM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):375-89. PubMed ID: 23116225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fixed combination of verapamil SR/trandolapril.
    Widimský J
    Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy.
    Epstein M; Bakris G
    Arch Intern Med; 1996 Sep; 156(17):1969-78. PubMed ID: 8823150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving blood pressure control rates by optimizing combination antihypertensive therapy.
    Epstein BJ
    Expert Opin Pharmacother; 2010 Aug; 11(12):2011-26. PubMed ID: 20590485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hypertension with fixed-dose triple-combination treatments.
    Epstein BJ; Shah NK; Borja-Hart NL
    Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):246-59. PubMed ID: 23945906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fixed-dose combinations in the first line of antihypertensive therapy].
    Urbán L; Mészáros A
    Acta Pharm Hung; 2007; 77(3):180-4. PubMed ID: 18019783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.
    Sica DA
    Drugs; 2002; 62(3):443-62. PubMed ID: 11827559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy.
    Basile J; Neutel J
    Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):119-27. PubMed ID: 20042448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global approach to hypertension.
    van den Meiracker AH
    EuroIntervention; 2013 May; 9 Suppl R():R16-20. PubMed ID: 23732150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free versus Fixed Combination Antihypertensive Therapy for Essential Arterial Hypertension: A Systematic Review and Meta-Analysis.
    Mallat SG; Tanios BY; Itani HS; Lotfi T; Akl EA
    PLoS One; 2016; 11(8):e0161285. PubMed ID: 27548060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
    Kreutz R; Scholze J; Douros A
    Curr Vasc Pharmacol; 2018 Jan; 16(2):197-203. PubMed ID: 28828980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using fixed-dose combination therapies to achieve blood pressure goals.
    Chrysant SG
    Clin Drug Investig; 2008; 28(11):713-34. PubMed ID: 18840014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological management of hypertension in the elderly and frail populations.
    Correa A; Rochlani Y; Khan MH; Aronow WS
    Expert Rev Clin Pharmacol; 2018 Aug; 11(8):805-817. PubMed ID: 30004797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.